INTS Intensity Therapeutics, Inc.
$4.02▼ -0.50%
Healthcare
Other
After hours
$4.02▲ +0.00%
Sep 11, 7:30 PM ET
Volume 10.5K
Avg Volume (10D) 17.6K
Key Metrics & Fundamentals
Market Cap
$13.12M
P/E Ratio
–
Div Yield
–%
52W Range
3.51 - 43.50
% vs 50 MA
-8.08%
% vs 200 MA
-37.89%
RSI-14
42.2
MACD Histogram
-0.0400
Beta (1Y vs SPY)
-1.54
Free Cash Flow
-$2.34M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.08M
COGS
–
Operating Exp
$3.08M
Operating Income
-$3.08M
EBIT
-$3.08M
Pretax Income
-$3.01M
Net Income
-$3.01M
EPS (Diluted)
-1.11
Price & Volume History
Loading chart…
Recent News
Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · Sep 8, 2026 12:00 PM
Intensity Therapeutics, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 12, 2026 2:22 AM
Intensity Therapeutics (INTS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 12, 2026 1:57 AM
Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
PR Newswire · Aug 11, 2026 11:30 AM
Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026
PR Newswire · Aug 4, 2026 12:00 PM
Soft Tissue Sarcoma Market Set for Significant Growth at a CAGR of 7.9% During the Forecast Period (2026-2036), Driven by Novel Therapies and Expanding Treatment Landscape | DelveInsight
PR Newswire · Jul 15, 2026 2:31 PM
Intensity Therapeutics Resumes Dosing in Phase 2 Trial for Investigational Cancer Therapy in Switzerland
MT Newswires · Jul 15, 2026 12:15 PM
Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study)
PR Newswire · Jul 15, 2026 11:45 AM
Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6
PR Newswire · Jul 1, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See INTS's money flow as a full page
Social Sentiment
Avg +0.35 · 2 posts
DiscussionTradeShould I just give up & start NEW with ETFS?
r/wallstreetbets · Oct 31, 2025
The post describes a loss with INTS, conveying a negative sentiment.
negative
-0.10
NewsDiscussionINTS today? New cancer drug results
r/wallstreetbets · Oct 30, 2025
New cancer drug results with improved metrics (disease control, mOS) create a positive outlook.
positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.